Format
Sort by
Items per page

Send to

Choose Destination

Best matches for INT J ONCOL[ta]:

Roles of STAT3 in leukemia (Review). Shi Y et al. Int J Oncol. (2018)

Mechanisms underlying the effects of stress on tumorigenesis and metastasis (Review). Zhang Z et al. Int J Oncol. (2018)

The Akt pathway in oncology therapy and beyond (Review). Nitulescu GM et al. Int J Oncol. (2018)

Search results

Items: 1 to 20 of 10483

1.

Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.

Yang W, Shi J, Zhou Y, Liu T, Zhan F, Zhang K, Liu N.

Int J Oncol. 2019 Jun 27. doi: 10.3892/ijo.2019.4833. [Epub ahead of print]

PMID:
31268166
2.

Suicide gene‑armed measles vaccine virus for the treatment of AML.

Maurer S, Salih HR, Smirnow I, Lauer UM, Berchtold S.

Int J Oncol. 2019 Jul 2. doi: 10.3892/ijo.2019.4835. [Epub ahead of print]

PMID:
31268165
3.

Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.

Wu HY, Peng ZG, He RQ, Luo B, Ma J, Hu XH, Dang YW, Chen G, Pan SL.

Int J Oncol. 2019 Jun 27. doi: 10.3892/ijo.2019.4834. [Epub ahead of print]

PMID:
31268164
4.

Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.

Kim SA, Lee KH, Lee DH, Lee JK, Lim SC, Joo YE, Chung IJ, Noh MG, Yoon TM.

Int J Oncol. 2019 Jul 2. doi: 10.3892/ijo.2019.4836. [Epub ahead of print]

PMID:
31268163
5.

SOX4 regulates invasion of bladder cancer cells via repression of WNT5a.

Moran JD, Kim HH, Li Z, Moreno CS.

Int J Oncol. 2019 Jun 26. doi: 10.3892/ijo.2019.4832. [Epub ahead of print]

PMID:
31268162
6.

miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.

Deng LM, Tan T, Zhang TY, Xiao XF, Gu H.

Int J Oncol. 2019 Jun 25. doi: 10.3892/ijo.2019.4831. [Epub ahead of print]

PMID:
31268161
7.

[Corrigendum] All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway.

Wu N, Li R, Meng Z, Nie M, Chen Q, He B, Deng Z, Yin L.

Int J Oncol. 2019 May 29. doi: 10.3892/ijo.2019.4817. [Epub ahead of print]

PMID:
31268160
8.

Upregulation of fascin-1 is involved in HIF-1α-dependent invasion and migration of hypopharyngeal squamous cell carcinoma.

Bu M, Liu X, Liu X, Xu W.

Int J Oncol. 2019 Jun 19. doi: 10.3892/ijo.2019.4827. [Epub ahead of print]

PMID:
31268159
9.

Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.

Yen CC, Chen LT, Li CF, Chen SC, Chua WY, Lin YC, Yen CH, Chen YC, Yang MH, Chao Y, Fletcher JA.

Int J Oncol. 2019 Jun 21. doi: 10.3892/ijo.2019.4829. [Epub ahead of print]

PMID:
31268158
10.

Effects of tobacco abuse on major chromosomal instability in human papilloma virus 16-positive oropharyngeal squamous cell carcinoma.

Villepelet A, Hugonin S, Atallah S, Job B, Baujat B, Lacau St Guily J, Lacave R.

Int J Oncol. 2019 Jun 18. doi: 10.3892/ijo.2019.4826. [Epub ahead of print]

PMID:
31268157
11.

HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma.

Won HR, Lee DH, Yeon SK, Ryu HW, Kim GW, Kwon SH.

Int J Oncol. 2019 Jun 20. doi: 10.3892/ijo.2019.4828. [Epub ahead of print]

PMID:
31268156
12.

Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment.

Wierzbicki PM, Klacz J, Kotulak-Chrzaszcz A, Wronska A, Stanislawowski M, Rybarczyk A, Ludziejewska A, Kmiec Z, Matuszewski M.

Int J Oncol. 2019 Jun 25. doi: 10.3892/ijo.2019.4830. [Epub ahead of print]

PMID:
31268155
13.

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.

Owusu-Ansah KG, Song G, Chen R, Edoo MIA, Li J, Chen B, Wu J, Zhou L, Xie H, Jiang D, Zheng S.

Int J Oncol. 2019 Jun 14. doi: 10.3892/ijo.2019.4825. [Epub ahead of print]

PMID:
31268154
14.

Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer.

Wang W, Liu L, Zhou Y, Ye Q, Yang X, Jiang J, Ye Z, Gao F, Tan X, Zhang G, Fang Q, Xuan ZX.

Int J Oncol. 2019 Jun 12. doi: 10.3892/ijo.2019.4824. [Epub ahead of print]

PMID:
31268153
15.

Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway.

Jiang ZC, Chen XJ, Zhou Q, Gong XH, Chen X, Wu WJ.

Int J Oncol. 2019 Jul;55(1):21-34. doi: 10.3892/ijo.2019.4816. Epub 2019 May 29.

16.

Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.

Guan W, Wang X, Lin Q, Zhang J, Ren W, Xu G.

Int J Oncol. 2019 Jul;55(1):267-276. doi: 10.3892/ijo.2019.4815. Epub 2019 May 28.

PMID:
31180557
17.

Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A.

Liu H, Lindbo S, Ding H, Altai M, Garousi J, Orlova A, Tolmachev V, Hober S, Gräslund T.

Int J Oncol. 2019 Jul;55(1):309-319. doi: 10.3892/ijo.2019.4814. Epub 2019 May 28.

PMID:
31180549
18.

Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo.

Ye J, Qi L, Chen K, Li R, Song S, Zhou C, Zhai W.

Int J Oncol. 2019 Jul;55(1):331-339. doi: 10.3892/ijo.2019.4820. Epub 2019 May 31.

PMID:
31180536
19.

Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.

Kumanishi S, Yamanegi K, Nishiura H, Fujihara Y, Kobayashi K, Nakasho K, Futani H, Yoshiya S.

Int J Oncol. 2019 Jul;55(1):167-178. doi: 10.3892/ijo.2019.4811. Epub 2019 May 23.

PMID:
31180533
20.

S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.

Nakayama H, Ohuchida K, Yonenaga A, Sagara A, Ando Y, Kibe S, Takesue S, Abe T, Endo S, Koikawa K, Okumura T, Shido K, Miyoshi K, Nakata K, Moriyama T, Miyasaka Y, Inoue S, Ohtsuka T, Mizumoto K, Nakamura M.

Int J Oncol. 2019 Jul;55(1):211-222. doi: 10.3892/ijo.2019.4812. Epub 2019 May 24.

PMID:
31180531

Supplemental Content

Loading ...
Support Center